Societal CDMO, Inc. Sustainability Profile
Societal CDMO, Inc., a prominent player in the contract development and manufacturing organisation (CDMO) sector, is headquartered in the United States. Founded in 2018, the company has rapidly established itself as a leader in the pharmaceutical and biotechnology industries, specialising in the development and production of complex drug formulations. With a focus on injectable and oral dosage forms, Societal CDMO offers unique capabilities in both small and large molecule manufacturing. The company’s state-of-the-art facilities and commitment to quality have garnered recognition, positioning it as a trusted partner for clients seeking innovative solutions. Notable achievements include successful collaborations with various biotech firms, underscoring its reputation for excellence in the CDMO landscape.
DitchCarbon Score
How does Societal CDMO, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Societal CDMO, Inc.'s score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Societal CDMO, Inc.'s reported carbon emissions
Societal CDMO, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. It is important to note that Societal CDMO, Inc. is a current subsidiary and may inherit emissions data and climate initiatives from its parent organisation. However, no specific data or targets have been cascaded from the parent company, which limits the available information on their climate commitments. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to address climate change. As a subsidiary, Societal CDMO, Inc. may benefit from future directives or strategies from its parent company that could enhance its climate action efforts.
How Carbon Intensive is Societal CDMO, Inc.'s Industry?
How Carbon Intensive is Societal CDMO, Inc.'s Location?
Societal CDMO, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Societal CDMO, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Boehringer Ingelheim Pharmaceuticals, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.